Spectral AI Inc. (MDAI)
NASDAQ: MDAI
· Real-Time Price · USD
1.29
-0.01 (-0.77%)
At close: May 01, 2025, 3:59 PM
1.28
-0.79%
After-hours: May 01, 2025, 06:05 PM EDT
Company Description
Spectral AI, Inc. operates as an artificial intelligence (AI) company.
The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.
Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention.
The company is based in Dallas, Texas.
Spectral AI Inc.

Country | United States |
IPO Date | Apr 6, 2021 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 78 |
CEO | Wensheng Fan |
Contact Details
Address: 2515 McKinney Avenue Dallas, Texas United States | |
Website | https://www.spectral-ai.com |
Stock Details
Ticker Symbol | MDAI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001833498 |
CUSIP Number | 84757T105 |
ISIN Number | US84757T1051 |
Employer ID | 00-0000000 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Erich L. Spangenberg | Chief Executive Officer of Health Care & Director |
Wensheng Fan | Co-Founder, Chief Innovation Strategist & Senior Advisor to the Chief Executive Officer |
Stan Micek | Chief Operating Officer |
Vincent Stanley Capone | Chief Financial Officer, General Counsel & Corporate Secretary |
Christine Marks | Vice President of Marketing & Commercialization |
Dr. John Michael DiMaio M.D. | Founder & Chairman |
Jeremiah A. Sparks MBA | Chief Commercialization Officer |
Louis Percoco | General Manager |
Prof. Paul Chadwick | Executive Vice President of UK & EMEA |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 25, 2025 | S-3 | Filing |
Apr 17, 2025 | DEFA14A | Filing |
Apr 17, 2025 | DEF 14A | Filing |
Apr 02, 2025 | 8-K | Current Report |
Mar 31, 2025 | 10-K | Annual Report |
Mar 26, 2025 | 8-K | Current Report |
Mar 21, 2025 | 424B5 | Filing |
Mar 17, 2025 | 8-K | Current Report |
Mar 04, 2025 | 8-K | Current Report |
Mar 04, 2025 | 8-K | Current Report |